These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2534675)

  • 1. [A hypothesis for pharmacologic research on GABAergic approaches in Huntington chorea].
    Vamvakides A
    Ann Pharm Fr; 1989; 47(5):259-65. PubMed ID: 2534675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Working hypothesis for the effect of GABAergic, glycinergic or glutamatergic drugs in the treatment of Parkinson disease].
    Vamvakidès A
    Ann Pharm Fr; 1990; 48(2):70-80. PubMed ID: 2291602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS
    J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Huntington's chorea].
    Benarroch EE
    Medicina (B Aires); 1981; 41(1):114-8. PubMed ID: 6455582
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease.
    Bosch M; Pineda JR; Suñol C; Petriz J; Cattaneo E; Alberch J; Canals JM
    Exp Neurol; 2004 Nov; 190(1):42-58. PubMed ID: 15473979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are there glutamatergic, anti-GABAergic or antiglycinergic components in the action mechanism of adamantamines? Study of convulsions induced by amantadine or 1-adamantylcyclopentanamine in mice].
    Vamvakides A
    Ann Pharm Fr; 1990; 48(6):312-20. PubMed ID: 2131763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and postsynaptic modulation of glycinergic and gabaergic transmission by muscarinic receptors on rat hypoglossal motoneurons in vitro.
    Pagnotta SE; Lape R; Quitadamo C; Nistri A
    Neuroscience; 2005; 130(3):783-95. PubMed ID: 15590160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease: genetics, chemical pathology, and management.
    Myers RH; Schoenfeld M; Bird ED
    Prog Med Genet; 1985; 6():91-122. PubMed ID: 2873625
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex.
    de Almeida J; Mengod G
    J Neurochem; 2007 Oct; 103(2):475-86. PubMed ID: 17635672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders of nocturnal sleep in Huntington chorea].
    Iakhno NN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):340-6. PubMed ID: 2986395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A/7 receptor agonist excites cardiac vagal neurons via inhibition of both GABAergic and glycinergic inputs.
    Chen YH; Hou LL; Wang JJ
    Acta Pharmacol Sin; 2008 May; 29(5):529-38. PubMed ID: 18430360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult onset myoclonic Huntington's disease.
    Carella F; Scaioli V; Ciano C; Binelli S; Oliva D; Girotti F
    Mov Disord; 1993 Apr; 8(2):201-5. PubMed ID: 8474490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staggered development of GABAergic and glycinergic transmission in the MNTB.
    Awatramani GB; Turecek R; Trussell LO
    J Neurophysiol; 2005 Feb; 93(2):819-28. PubMed ID: 15456797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin facilitates glycinergic and GABAergic synaptic transmission in developing hypoglossal motoneurons.
    Reymond-Marron I; Raggenbass M; Zaninetti M
    Eur J Neurosci; 2005 Mar; 21(6):1601-9. PubMed ID: 15845087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain.
    Chen YP; Chen SR; Pan HL
    J Pharmacol Exp Ther; 2005 Nov; 315(2):696-703. PubMed ID: 16033910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage gated P/Q and N-type calcium channels mediate the nicotinic facilitation of GABAergic and glycinergic inputs to cardiac vagal neurons.
    Wang X; Evans C; Mendelowitz D
    Neuropharmacology; 2004 Mar; 46(3):372-8. PubMed ID: 14975692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.